Labiotech.eu, a biotechnology-centered online issue, published an article about exosomes, featuring Exogenus Therapeutics as one of the leading exosome biotechnology companies in Europe. The piece delves into the most recent advances in exosome-based therapeutics and vesicle manufacturing, offering an up-to-date and accessible account of the industry’s most promising candidates.
Alongside Exogenus Therapeutics, the article features UK-based Evox Therapeutics and the French GMP manufacturer EVerZom. We are proud to be among Europe’s leading exosome biotechnology companies, working to advance the field and reach patients in need.
To read the full article, click here.